1,402
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Periodontitis & preeclampsia: were outer membrane vesicles a potential connection?

, , , ORCID Icon &
Article: 2183767 | Received 19 Feb 2022, Accepted 18 Feb 2023, Published online: 01 Mar 2023

Abstract

Introduction

Preeclampsia (PE) is gestation-specific hypertension coupled by systemic multiple organ damages, remaining the leading causes of maternal and infant death worldwide.

Materials and methods

Though numerous pathogenetic mechanisms have been engaged in this disorder and several methods have been undertaken to treat PE, few clinical strategies are effective in PE management, suggesting more studies from novel perspective being in great need to decipher the underlying mechanisms of PE.

Results

Growing evidence shows that women with periodontitis, an oral microflora-induced chronic inflammation of the periodontal tissues, are more inclined to suffer PE, which may be tightly associated with microflora-derived outer membrane vesicles (OMVs). Latest studies reveal that OMVs are spherical membrane-enclosed entities released by bacteria and can gain free access to the circulation of the host and therefore reach the remote tissue of the host, participating the interaction among oral bacterial with the host and contribute to some systemic disease with carried bioactive materials.

Conclusions

OMVs may be the underlying mechanism linking oral flora-induced periodontitis with dysfunction trophoblast and finally contributes to the pathogenesis of in PE. Here we provide evidence to support the potential roles of OMVs linking periodontal disease between PE.

Background

Preeclampsia (PE) is characterized by de novo hypertension after 20 weeks of gestation and systemic multiple organ damages, which is one of the leading causes of maternal death and the delivery of placental tissue remains the only definitive therapy [Citation1]. Although the related therapeutic measures can improve the acute symptoms of the patient, they cannot fundamentally reverse the progression of the disease and ultimately prevent the occurrence of PE, suggesting that there may be other unknown factors involved in the occurrence and development of PE.

Periodontitis is a chronic inflammation of the periodontal tissues such as gums, periodontal ligament, alveolar bone, or cementum, with clinical manifestations of red and swollen gums, periodontal pocket pus discharge and tooth loosening, which is the main cause of tooth loss in adults [Citation2]. Despite that oral microflora, the second largest microbial community, remains a steady-state balance in normal cases, periodontitis is mainly induced by the changes in the characteristics of oral microbial flora including Actinomyces actinomycetemcomitans (Aa), Porphyromonas gingivalis (Pg), Fusobacterium nucleatum, Prevotella intermedia and Treponema denticulatum. A study conducted by Duke University showed that pregnant women with periodontal disease had significantly higher probability of PE during delivery than their counterparts with good oral condition, and that periodontal disease progressed easily during pregnancy [Citation3]. However, it is not clear how the remote oral flora engages in the occurrence and development of PE.

Latest research reported that all life-forms secrete cellular components across their plasma membrane to interact with their outside environments and one way for microbial flora accomplishes this is by secreting outer membrane vesicles (OMVs) [Citation4]. A variety of bioactive substances such as lipids, protein, and nucleic acids are carried and transported by OMVs, which could penetrate the blood-brain barrier and the blood-fetal barrier [Citation5]. With the increasing understanding of OMVs, researchers find that OMVs emerge as distinct cellular entities and help bacteria adapt to diverse niches, compete to survive, and more surprisingly play a significant role in the interaction between host and pathogen and are associated with a range of diseases including myocardial infarction, Alzheimer’s disease, diabetes, and other systemic diseases [Citation6]. In this article, we will provide evidence to support the potential roles of OMVs linking periodontal disease between PE.

Enigmatic pathogenesis of PE

Though major advances have been achieved in various medical puzzles in numerous fields, PE is still the tough problem in obstetrics and gynecology and remains the leading cause of maternal and infant death, with placenta delivery being the only definitive therapy. Nowadays, most researchers hold the view that there were two subtypes of PE: early and late onset forms and that they arise owing to quite different pathogenesis. Early onset PE may center around compromised placentation, whist the late form is associated with the imbalance between uterine perfusion and progressive fetoplacental demands, coupled with a maternal genetic predisposition to cardiovascular and metabolic disease [Citation7,Citation8]. In addition, placental ischemia and hypoxia, oxidative stress, endoplasmic reticulum stress, changes in cytokines and complement levels, autoantibody production, and neurohumoral imbalance also play important roles in the pathogenesis of PE [Citation9]. A large number of scholars from different entry points to use aspirin [Citation10], magnesium sulfate [Citation11], vitamin D [Citation12], acetylcholinesterase inhibitor [Citation13], 17-alpha-hydroxyprogesterone caproate [Citation14–16] and Mito Q [Citation17] for the treatment of PE. However, these methods could not solve PE, suggesting other unknown factors engaged in the pathogenesis of PE. More studies from novel perspective are in great need to decipher the underlying mechanisms of oral flora imbalance in the pathogenesis of PE.

Inclination of perinatal periodontitis patients to PE

The oral microflora is the second largest microbial community in the human body after the intestinal flora, and it maintains a steady-state balance with the body under normal conditions [Citation2]. However, in some cases, the imbalance of oral flora composition can cause chronic inflammation of periodontal tissues (periodontitis), which includes inflammation of gums, periodontal ligament, alveolar bone, and cementum [Citation18]. Its risk factors include female, environmental factors, smoking and HLA-DRB1 SE phenotype [Citation3]. In recent years, with the increasing emphasis on oral health, researchers have gradually found that the imbalance of oral flora not only affects the local oral cavity, but is also related to myocardial infarction, Alzheimer’s disease, diabetes, and other systemic diseases [Citation6].

Subsequent studies revealed a significant association between periodontal disease and premature birth, low birth weight, abortion, and PE in women of childbearing age. Some researchers hold the view that periodontitis and PE may be presented as symptoms of an underlying pathophysiologic mechanism, or maybe even a reverse mechanism: the maternal gestational (immunologic) changes as potential inductor of periodontitis. Other scholars believe that inflammatory factors such as TNF-α and IL-6, released by local periodontal inflammation, may be the key to the correlation between periodontitis and PE. To test this hypothesis, Professor Politano GT’s team included 58 parturient with PE and 58 healthy controls in the study and showed that there was a correlation between periodontitis and PE (OR 3.73; 95%CI 1.32–10.58), but the levels of circulating TNF-α and IL-6 levels in PE patients had no significant correlation with the occurrence of periodontitis [Citation19]. Besides, clinical observation studies have shown that approximately 63.8% of patients with PE have periodontal disease, compared with 36.6% of healthy controls in the same period and that the occurrence of periodontal disease is significantly related to the occurrence of PE (p < 0.001) [Citation20,Citation21]. The underlying mechanisms linking periodontitis and beforementioned systemic disease as well as PE remain poor understood.

Microflora-derived OMVs and its detrimental effects in diseases

In 1965, Bishop and his collaborators first observed that OMV was released by auxotrophic Escherichia coli strain under a limited lysine condition [Citation22]. Later, Knox et al. employed electron microscopy to identified that these secreted cellular components were spherical, nano-sized entities and from the outer membrane of gram-negative bacteria and of endocytic origin [Citation23]. OMVs are rich in toxins, bioactive proteins, and virulence factors and are engaged in bacteria-bacteria and even bacteria-host interactions [Citation24]. Remote tissues and cells can ingest circulating OMVs and lead to phenotypic and functional changes [Citation25–30].

Ozaki’s team found that OMVs released by Pg were equipped with Pg-derived proteases gingipains and these OMVs could transferred to mice liver, which inhibited the insulin-induced Akt-GSK-3β signaling cascade and contributed to the development of diabetes mellitus [Citation31]. With the expanding knowledge of OMVs, researchers find that OMVs could penetrate the blood-brain barrier and the blood-fetal barrier [Citation5]. Nonpathogenic E. coli-derived OMVs contained LPS and was able to induce systemic inflammation and even bacterial sepsis in mice [Citation32]. Han et al. reported that oral Aggregatibacter actinomycetemcomitans-derived OMVs crossed the blood-brain barrier in mice and promoted the production of TNF-α in macrophages, linking periodontal disease to neuroinflammatory disease [Citation33]. Jose et al. found that enterotoxigenic Escherichia coli-derived OMVs could pass the placenta barrier and changed the pregnancy outcomes [Citation34]. With the increasing understanding of OMVs, researchers are aware that OMVs emerge as distinct cellular entities and help bacteria adapt to diverse niches, compete to survive, and more surprisingly play a significant role in the interaction between host and pathogen and are associated with a range of diseases including myocardial infarction, Alzheimer’s disease, diabetes, and other systemic diseases [Citation6].

Is placental trophoblast a potential target of OMVs?

Trophoblast is the basic functional cell of placenta, which plays a vital role in embryonic development and pregnancy maintenance. The abnormal function of trophoblast is related to the abnormal placentation in the early stage of gestation and is thought to trigger PE. Compromised trophoblast cells may release a large number of toxic substances such as inflammatory cytokines, anti-angiogenic factors, and free fetal DNA into the maternal circulation and induce extensive endothelial damage, the typical hallmark of PE [Citation7]. Moreover, most of the symptoms in severe PE patients can be relieved after the delivery of placental tissue, which once again proves the importance of placenta with trophoblast as the main structure in the pathogenesis of PE. Importantly, a large number of studies have shown that vesicles derived from endothelial, trophoblast, macrophage and other different sources could be uptaken by placental trophoblast and resulted in defective angiogenesis, inflammation and vascular mechanism, which is closely related to the pathogenesis of PE [Citation35–43].

A Japanese study found that the level of Aa was not increased in the circulation of PE women in comparison with normal control, which has been the most recognized pathogenic bacteria in the development of periodontitis. This study suggested that pathogenic bacteria didn’t induce PE via the direct invasion into maternal circulation [Citation44]. In our unpublished work as well as others’, OMVs have been reported as being stable and capable of passing through the blood-brain barrier and placental barrier, giving rising to the possibility that OMVs from oral flora could act as an information transmitter to remotely regulate and mediate the occurrence and development of systemic diseases [Citation34]. Given that recent blockbuster studies pointed out that OMVs released by intestinal or oral flora were not only ingested by distant organs such as liver, spleen, and heart, but also ingested by neurons after crossing the blood-brain barrier, OMVs might be the breakthrough point for research on the damage to distant organs caused by the imbalance of flora, including placenta. Some OMVs released by some pathogenic bacteria after oral flora imbalance might participate in the cross talk between oral flora and placenta, which finally contributes to the occurrence and development of PE.

Conclusion

Preeclampsia is a gestation-specific syndrome characterized by de novo hypertension and evidence of target organ dysfunction and remains one of the important causes of maternal and infant death. Though numerous pathogenetic mechanisms have been engaged in this disorder and several methods have been undertaken to treat PE, few clinical strategies are effective in PE management, suggesting more studies from novel perspective being in great need to decipher the underlying mechanisms of PE. Previous studies reported a strong relationship between PE and oral microflora-induced periodontitis. Further studies added that microflora-derived OMVs are rich in toxins, bioactive proteins, and virulence factors and are engaged in bacteria-bacteria and even bacteria-host interactions. Given the potential of OVMs shuttling from oral cave to placenta with bioactive materials, it is suggested that OMVs may be the underlying mechanism linking oral flora-induced periodontitis with dysfunction trophoblast and finally contributes to the pathogenesis of in PE (). Deciphering the role of OMVs in PE is expected to deepen current understanding of this life-threatening disease, provide new theoretical basis and for drug intervention and clinical management of PE.

Figure 1. Outer membrane vesicles released by imbalanced oral flora may be engaged in the dysfunction of trophoblast and finally contribute to the pathogenesis of preeclampsia.

Figure 1. Outer membrane vesicles released by imbalanced oral flora may be engaged in the dysfunction of trophoblast and finally contribute to the pathogenesis of preeclampsia.

Disclosure statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Additional information

Funding

This work was supported by National Natural Science Foundation of China 82071670 (Jinjun Liu), 81771616 (Jinjun Liu), Grant for A-level Department (Oral Microflora Involved in the Pathogenesis of Pre-eclampsia through Outer Membrane Vesicles, 2022) and Shaanxi Key Research and Development Program [2022SF-102] to Chunfang Li.

References

  • Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43.
  • Contreras A, Herrera JA, Soto JE, et al. Periodontitis is associated with preeclampsia in pregnant women. J Periodontol. 2006;77(2):182–188.
  • Boggess KA, Lieff S, Murtha AP, et al. Maternal periodontal disease is associated with an increased risk for preeclampsia. Obstet Gynecol. 2003;101:227–231.
  • Yáñez-Mó M, Siljander PRM, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:1–60.
  • Jan AT. Outer Membrane Vesicles (OMVs) of gram-negative bacteria: a perspective update. Front Microbiol. 2017;8:1–11.
  • Olsen I. From the acta prize lecture 2014: the periodontalsystemic connection seen from a microbiological standpoint. Acta Odontol Scand. 2015;73(8):563–568.
  • Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:1–15.
  • Rana S, Lemoine E, Granger J, et al. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094–1112.
  • Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480.
  • Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
  • Johnson AC, Tremble SM, Chan S, et al. Magnesium sulfate treatment reverses seizure susceptibility and decreases neuroinflammation in a rat model of severe preeclampsia. PLoS One. 2014;9:e113670.
  • Tian X, Ma S, Wang Y, et al. Effects of placental ischemia are attenuated by 1,25-Dihydroxyvitamin D treatment and associated with reduced apoptosis and increased autophagy. DNA Cell Biol. 2016;35(2):59–70.
  • Issotina Zibrila A, Wang Z, Ali MA, et al. Pyridostigmine ameliorates preeclamptic features in pregnant rats by inhibiting tumour necrosis factor-α synthetsis and antagonizing tumour necrosis factor-α-related effects. J Hypertens. 2021;39(9):1774–1789.
  • Amaral LM, Cornelius DC, Harmon A, et al. 17-Hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension. 2015;65(1):225–231.
  • Veillon EW, Keiser SD, Parrish MR, et al. 17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats. Am J Obstet Gynecol. 2009;201(3):324.e1–324–e6.
  • Amaral LM, Faulkner JL, Elfarra J, et al. Continued investigation into 17-OHPC: results from the preclinical RUPP rat model of preeclampsia. Hypertension. 2017;70(6):1250–1255.
  • Vaka VR, McMaster KM, Cunningham MW, et al. Role of mitochondrial dysfunction and reactive oxygen species in mediating hypertension in the reduced uterine perfusion pressure rat model of preeclampsia. Hypertension. 2018;72(3):703–711.
  • Kunnen A, Blaauw J, Van Doormaal JJ, et al. Women with a recent history of early-onset pre-eclampsia have a worse periodontal condition. J Clin Periodontol. 2007;34(3):202–207.
  • Politano GT, Passini R, Nomura ML, et al. Correlation between periodontal disease, inflammatory alterations and pre-eclampsia. J Periodontal Res. 2011;46(4):505–511.
  • Ahmadian E, Rahbar Saadat Y, Hosseiniyan Khatibi SM, et al. Pre-eclampsia: microbiota possibly playing a role. Pharmacol Res. 2020;155:104692.
  • Boggess KA, Society for Maternal-Fetal Medicine Publications Committee. Maternal oral health in pregnancy. Obstet Gynecol. 2008;111(4):976–986.
  • Bishop DG, Work E. An extracellular glycolipid produced by Escherichia coli grown under lysine-limiting conditions. Biochem J. 1965;96(2):567–576.
  • Knox KW, Vesk M, Work E. Relation between excreted lipopolysaccharide complexes and surface structures of a lysine-limited culture of Escherichia coli. J Bacteriol. 1966;92(4):1206–1217.
  • Vestad B, Llorente A, Neurauter A, et al. Size and concentration analyses of extracellular vesicles by nanoparticle tracking analysis: a variation study. J Extracell Vesicles. 2017;6:1344087.
  • Karpman D, Ståhl AL, Arvidsson I. Extracellular vesicles in renal disease. Nat Rev Nephrol. 2017;13(9):545–562.
  • Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659.
  • Morelli AE, Larregina AT, Shufesky WJ, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004;104(10):3257–3266.
  • Feng D, Zhao WL, Ye YY, et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 2010;11(5):675–687.
  • Christianson HC, Svensson KJ, Van Kuppevelt TH, et al. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci U S A. 2013;110(43):17380–17385.
  • Parolini I, Federici C, Raggi C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284(49):34211–34222.
  • Seyama M, Yoshida K, Yoshida K, et al. Outer membrane vesicles of Porphyromonas gingivalis attenuate insulin sensitivity by delivering gingipains to the liver. Biochim Biophys Acta Mol Basis Dis. 2020;1866(6):165731.
  • Santos JC, Dick MS, Lagrange B, et al. LPS targets host guanylate‐binding proteins to the bacterial outer membrane for non‐canonical inflammasome activation. Embo J. 2018;37:1–19.
  • Han EC, Choi SY, Lee Y, et al. Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-α production in human macrophages and cross the blood-brain barrier in mice. Faseb J. 2019;33(12):13412–13422.
  • Matías J, Brotons A, Cenoz S, et al. Oral immunogenicity in mice and sows of enterotoxigenic Escherichia coli outer‐membrane vesicles incorporated into zein‐based nanoparticles. Vaccines. 2020;8:1–12.
  • Tramontano AF, Lyubarova R, Tsiakos J, et al. Circulating endothelial microparticles in diabetes mellitus. Mediators Inflamm. 2010;2010:250476.
  • Zhang X, McGeoch SC, Johnstone AM, et al. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J Thromb Thrombolysis. 2014;37(4):455–463.
  • Strano A, Davi G, Patrono C. In vivo platelet activation in diabetes mellitus. Semin Thromb Hemost. 1991;17(4):422–425.
  • Preston RA, Jy W, Jimenez JJ, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension. 2003;41(2):211–217.
  • Lacroix R, Dignat-George F. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb Res. 2012;129: S27–S29.
  • Nielsen CT, Østergaard O, Johnsen C, et al. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum. 2011;63(10):3067–3077.
  • Dignat-George F, Camoin-Jau L, Sabatier F, et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost. 2004;91(4):667–673.
  • Sabatier F, Darmon P, Hugel B, et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes. 2002;51(9):2840–2845.
  • Stepanian A, Bourguignat L, Hennou S, et al. Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss. Obesity (Silver Spring). 2013;21(11):2236–2243.
  • Hirano E, Sugita N, Kikuchi A, et al. The association of Aggregatibacter actinomycetemcomitans with preeclampsia in a subset of Japanese pregnant women. J Clin Periodontol. 2012;39(3):229–238.